Integra LifeSciences (IART) Reports In-Line Q2 EPS; Tightens FY Rev Range

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to Integra LifeSciences (IART) Reports In-Line Q2 EPS; Tightens FY Rev Range

Integra LifeSciences Reports Second Quarter 2017 Financial Results

July 26, 2017 6:00 AM EDT

Revenue Increased 13.2% to $282.2 million; Organic Revenue Increased 4.6%

 Reported EPS of $0.14; Adjusted EPS of $0.45, up 12.5%

PLAINSBORO, N.J., July 26, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported its financial results for the second quarter ending June 30, 2017.

Highlights:

... More